Metabolic syndrome and liver transplantation: A review and guide to management

Angulo, 2006, Nonalcoholic fatty liver disease and liver transplantation, Liver Transpl, 12, 523, 10.1002/lt.20738 Charlton, 2004, Nonalcoholic fatty liver disease: a review of current understanding and future impact, Clin Gastroenterol Hepatol, 2, 1048, 10.1016/S1542-3565(04)00440-9 Adam, 2003, Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry, Liver Transpl, 9, 1231, 10.1016/j.lts.2003.09.018 Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Grundy, 2001 Ford, 2002, Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356 Ford, 2004, Increasing prevalence of the metabolic syndrome among U.S. adults, Diabetes Care, 27, 2444, 10.2337/diacare.27.10.2444 Gami, 2007, Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies, J Am Coll Cardiol, 49, 403, 10.1016/j.jacc.2006.09.032 Girman, 2004, The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex-CAPS), Am J Cardiol, 93, 136, 10.1016/j.amjcard.2003.09.028 Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, 2709, 10.1001/jama.288.21.2709 Tellez-Avila, 2008, Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis, World J Gastroenterol, 14, 4771, 10.3748/wjg.14.4771 Poonawala, 2000, Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study, Hepatology, 32, 689, 10.1053/jhep.2000.17894 Watt, 2008, Risk factors associated with long-term mortality after liver transplantation: an analysis of the multi-center, prospective Niddk database, Hepatology, 48, 66 Pfitzmann, 2008, Long-term results after liver transplantation, Transpl Int, 21, 234, 10.1111/j.1432-2277.2007.00596.x Laryea, 2007, Metabolic syndrome in liver transplant recipients: prevalence and association with cardiovascular events, Liver Transpl, 13, 1109, 10.1002/lt.21126 Bianchi, 2008, Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression, Liver Transpl, 4, 1648, 10.1002/lt.21588 Johnston, 2002, Cardiovascular morbidity and mortality after orthotopic liver transplantation, Transplantation, 73, 901, 10.1097/00007890-200203270-00012 Vogt, 2002, The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation, Surgery, 132, 775, 10.1067/msy.2002.128343 Sturm, 2003, Increases in clinically severe obesity in the United States, 1986–2000, Arch Intern Med, 163, 2146, 10.1001/archinte.163.18.2146 Palaniappan, 2004, Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study, Diabetes Care, 27, 788, 10.2337/diacare.27.3.788 Alberti, 2005, The metabolic syndrome – a new worldwide definition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 Adams, 2005, Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition, Diabetes Care, 8, 2777, 10.2337/diacare.28.11.2777 Bays, 2008, Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Rev Cardiovasc Ther, 6, 343, 10.1586/14779072.6.3.343 Fox, 2007, Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study, Circulation, 116, 39, 10.1161/CIRCULATIONAHA.106.675355 Smith, 2001, Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity, Metabolism, 50, 425, 10.1053/meta.2001.21693 Everhart, 1998, Weight change and obesity after liver transplantation: incidence and risk factors, Liver Transpl Surg, 4, 285, 10.1002/lt.500040402 Richards, 2005, Weight gain and obesity after liver transplantation, Transpl Int, 18, 461, 10.1111/j.1432-2277.2004.00067.x Wawrzynowicz-Syczewska, 2009, Risk factors and dynamics of weight gain in patients after liver transplantation, Ann Transplant, 14, 45 Choban, 1997, The impact of obesity on surgical outcomes: a review, J Am Coll Surg, 185, 593, 10.1016/S1072-7515(97)00109-9 Hillingso, 2005, Obesity increases mortality in liver transplantation – the Danish experience, Transpl Int, 18, 1231, 10.1111/j.1432-2277.2005.00206.x Nair, 2002, Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States, Hepatology, 35, 105, 10.1053/jhep.2002.30318 Braunfeld, 1996, Liver transplantation in the morbidly obese, J Clin Anesth, 8, 585, 10.1016/S0952-8180(96)00142-0 Sawyer, 1999, Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation, Clin Transpl, 13, 126, 10.1034/j.1399-0012.1999.130111.x Keeffe, 1994, Liver transplantation in patients with severe obesity, Transplantation, 57, 309, 10.1097/00007890-199401001-00034 Fujikawa, 2006, Clinical and financial impact of obesity on the outcome of liver transplantation, Transplant Proc, 38, 3612, 10.1016/j.transproceed.2006.10.188 Nair, 2001, Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation, Am J Gastroenterol, 96, 842, 10.1111/j.1572-0241.2001.03629.x Leonard, 2008, The impact of obesity on longterm outcomes in liver transplant recipients – results of the NIDDK liver transplant database, Am J Transplant, 8, 667, 10.1111/j.1600-6143.2007.02100.x Dick, 2009, Liver transplantation at the extremes of the body mass index, Liver Transpl, 15, 968, 10.1002/lt.21785 Jensen, 1995, Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry, Am J Clin Nutr, 61, 274, 10.1093/ajcn/61.2.274 Fishbein, 1997, Use of livers with microvesicular fat safely expands the donor pool, Transplantation, 64, 248, 10.1097/00007890-199707270-00012 Christakis, 2007, The spread of obesity in a large social network over 32 years, N Engl J Med, 357, 370, 10.1056/NEJMsa066082 Stegall, 1995, Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity, Transplantation, 60, 1057 Kotlyar, 1999, Effects of obesity on the cytochrome P450 enzyme system, Int J Clin Pharmacol Ther, 37, 8 Cassiman, 2006, Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial, Transpl Int, 19, 1000, 10.1111/j.1432-2277.2006.00379.x Takata, 2008, Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation, Surg Obes Relat Dis, 4, 159, 10.1016/j.soard.2007.12.009 Butte, 2007, Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation, Obes Surg, 17, 1517, 10.1007/s11695-008-9432-z Campsen, 2008, Adjustable gastric banding in a morbidly obese patient during liver transplantation, Obes Surg, 18, 1625, 10.1007/s11695-008-9633-5 Megyesi, 1967, Glucose tolerance and diabetes in chronic liver disease, Lancet, 2, 1051, 10.1016/S0140-6736(67)90334-0 Perseghin, 2000, Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation, Hepatology, 31, 694, 10.1002/hep.510310320 Reuben, 2001, Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity, Liver Transpl, 7, S13, 10.1053/jlts.2001.29167 Moon, 2006, Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up, Transplantation, 82, 1625, 10.1097/01.tp.0000250361.60415.96 Baid, 2001, Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality, Transplantation, 72, 1066, 10.1097/00007890-200109270-00015 Colle, 2004, Transplanted liver: consequences of denervation for liver functions, Anat Rec A Discov Mol Cell Evol Biol, 280, 924, 10.1002/ar.a.20097 Schacke, 2002, Mechanisms involved in the side effects of glucocorticoids, Pharmacol Ther, 96, 23, 10.1016/S0163-7258(02)00297-8 Haddad, 2006, Cyclosporin versus tacrolimus for liver transplanted patients, Cochrane Database Syst Rev, 18, CD005161 Vodenik, 2009, Mammalian target of rapamycin and diabetes: what does the current evidence tell us?, Transplant Proc, 41, S31, 10.1016/j.transproceed.2009.06.159 Veldt, 2009, Insulin resistance, serum adipokines and the risk of fibrosis progression in patients transplanted for hepatitis C: a prospective cohort study, Am J Transplant, 9, 1406, 10.1111/j.1600-6143.2009.02642.x John, 2002, Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus, Liver Transpl, 8, 708, 10.1053/jlts.2002.34638 John, 2001, Outcome of liver transplantation in patients with diabetes mellitus: a case-control study, Hepatology, 34, 889, 10.1053/jhep.2001.29134 Yoo, 2002, The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation, Transplantation, 74, 1007, 10.1097/00007890-200210150-00019 2009, Standards of medical care in diabetes, Diabetes Care, 32, S13, 10.2337/dc09-S013 Belfort, 2006, A placebo-controlled trial pioglitazone in subjects with non-alcoholic steatohepatitis, N Engl J Med, 355, 2297, 10.1056/NEJMoa060326 Lutchman, 2007, The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis, Hepatology, 46, 424, 10.1002/hep.21661 Bonkovsky, 2002, Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone, Dig Dis Sci, 47, 1632, 10.1023/A:1015895925374 Nathan, 2007, Rosiglitazone and cardiotoxicity – weighing the evidence, N Engl J Med, 357, 64, 10.1056/NEJMe078117 Gisbert, 1997, Hyperlipidemia in liver transplant recipients: prevalence and risk factors, Liver Transpl Surg, 3, 416, 10.1002/lt.500030409 Neal, 2004, Is there disparity between risk and incidence of cardiovascular disease after liver transplant?, Transplantation, 77, 93, 10.1097/01.TP.0000100685.70064.90 Roy, 2006, Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant, Transplantation, 82, 494, 10.1097/01.tp.0000231711.82193.41 Canzanello, 1997, Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK 506), Liver Transpl Surg, 3, 1, 10.1002/lt.500030101 Sanchez, 2005, Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years, Transplant Proc, 37, 4416, 10.1016/j.transproceed.2005.10.019 Trotter, 2001, Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus, Liver Transpl, 7, 401, 10.1053/jlts.2001.23916 Morrisett, 2003, Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients, Transplant Proc, 35, 143S, 10.1016/S0041-1345(03)00233-1 Deters, 2003, Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat, Planta Med, 69, 337, 10.1055/s-2003-38870 Chan, 1998, The effects of liver transplantation and cyclosporine on bile formation and lipid composition: an experimental study in the rat, J Hepatol, 28, 329, 10.1016/0168-8278(88)80021-7 Muñoz, 1995, Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis, and management, Liver Transpl Surg, 1, 29 Klintmalm, 2007, Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study, Liver Transpl, 13, 1521, 10.1002/lt.21182 Martin, 2008, Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients, Clin Transplant, 22, 113, 10.1111/j.1399-0012.2007.00780.x Asberg, 2003, Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients, Drugs, 63, 367, 10.2165/00003495-200363040-00003 Mück, 2001, Tacrolimus/cerivastatin interaction study in liver transplant recipients, Br J Clin Pharmacol, 52, 213, 10.1046/j.0306-5251.2001.01424.x McKenney, 2007, Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia, Pharmacotherapy, 27, 715, 10.1592/phco.27.5.715 Lee, 2007, Omega-3 fatty acids and liver disease, Hepatology, 45, 841, 10.1002/hep.21645 Watson, 2009, Comparison of bleeding complications with omega-3 fatty acids+aspirin+clopidogrel versus aspirin+clopidogrel in patients with cardiovascular disease, Am J Cardiol, 104, 1052, 10.1016/j.amjcard.2009.05.055 Almutairi, 2009, Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia, Liver Transpl, 15, 504, 10.1002/lt.21710 Canzanello, 1998, Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506), Liver Transpl Surg, 4, 328, 10.1002/lt.500040404 Gonwa, 2003, Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months, Transplantation, 75, 1213, 10.1097/01.TP.0000062837.99400.60 Textor, 1993, De novo hypertension after liver transplantation, Hypertension, 22, 257, 10.1161/01.HYP.22.2.257 Neal, 2004, Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation, Transplantation, 77, 748, 10.1097/01.TP.0000116418.78963.DC Lubel, 2008, Liver disease and the renin-angiotensin system: recent discoveries and clinical implications, J Gastroenterol Hepatol, 23, 1327, 10.1111/j.1440-1746.2008.05461.x Chobanian, 2003, The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 Carey, 1995, The prevalence of coronary artery disease in liver transplant candidates over age 50, Transplantation, 59, 859, 10.1097/00007890-199503270-00010 Tiukinhoy-Laing, 2006, Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation, Am J Cardiol, 98, 178, 10.1016/j.amjcard.2006.01.089 Diedrich, 2008, Influence of coronary artery disease on outcomes after liver transplantation, Transplant Proc, 40, 3554, 10.1016/j.transproceed.2008.08.129 Gastaldelli, 2009, Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population, Hepatology, 49, 1537, 10.1002/hep.22845 Wilson, 2003, The metabolic syndrome: practical guide to origins and treatment: Part I, Circulation, 108, 1422, 10.1161/01.CIR.0000089505.34741.E5 Pawarode, 2003, Independent risk factors and natural history of renal dysfunction in liver transplant recipients, Liver Transpl, 9, 741, 10.1053/jlts.2003.50113 Charlton, 2001, Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease, Liver Transpl, 7, 608, 10.1053/jlts.2001.25453 Contos, 2001, Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis, Liver Transpl, 7, 363, 10.1053/jlts.2001.23011 Malik, 2009, Outcome after liver transplantation for NASH cirrhosis, Am J Transplant, 9, 782, 10.1111/j.1600-6143.2009.02590.x Seo, 2007, De novo nonalcoholic fatty liver disease after liver transplantation, Liver Transpl, 13, 844, 10.1002/lt.20932 Hanouneh, 2008, The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation, Liver Transpl, 14, 1287, 10.1002/lt.21524 Romero-Gomez, 2005, Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients, Gastroenterology, 128, 636, 10.1053/j.gastro.2004.12.049 Chen, 2009, New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies, Transpl Int, 22, 408, 10.1111/j.1432-2277.2008.00804.x Syed, 2010, Hepatitis C virus hijacks host lipid metabolism, Trends Endocrinol Metab, 21, 33, 10.1016/j.tem.2009.07.005 Corey, 2009, Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up, Hepatology, 50, 1030, 10.1002/hep.23219